A STUDY ON WHETHER AN ANTIHYPERTENSIVE MEDICATION PREVENTS DAMAGE TO WALLS OF VEINS IN FEMALE PATIENTS WITH THE METABOLIC SYNDROME (OVERWEIGHT AND OTHER DISORDERS).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
80
Change in baseline flow-mediated vasodilatation after 12 weeks
Change in baseline brachial artery flow after 12 weeks
Circulating markers of oxidation, inflammation, and fibrinolysis at baseline, 12 weeks
Adverse events and serious adverse events at each study visit for up to 12 weeks
Hematology, blood chemistries, and urine for up to 12 weeks
Vital signs, physical condition, and body weight for up to 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.